Names and pronunciation
(len-va′-ti-nib) Lenvima
PDF page 765
Drug reference
(len-va′-ti-nib) Lenvima
PDF page 765
Func. class.: Antineoplastic
PDF page 765
USES: Locally recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer (DTC)
PDF page 765
CONTRAINDICATIONS: Hyper- sensitivity
PDF page 765
DOSAGE AND ROUTES Thyroid cancer • Adult: PO 24 mg (two 10-mg capsules once daily Advanced renal cell carcinoma after 1 prior treatment, used with everolimus • Adult: PO 18 mg/day with everolimus 5 mg/day Hepatocellular cancer, unrectable • Adult ≥60 kg: PO 12 mg daily
PDF page 765
Available forms: Capsules 4, 8, 10, 12, 14, 18, 20, 24 mg
PDF page 765
• Adult: PO 24 mg (two 10-mg capsules once daily Advanced renal cell carcinoma after 1 prior treatment, used with everolimus
PDF page 765
• Adult: PO 18 mg/day with everolimus 5 mg/day Hepatocellular cancer, unrectable
PDF page 765
• Adult ≥60 kg: PO 12 mg daily
PDF page 765